GO:0030976 thiamine pyrophosphate binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030976 (thiamine pyrophosphate binding) is a molecular function describing the binding of thiamine pyrophosphate (TPP), the diphosphoric ester of thiamine, which acts as a coenzyme for several decarboxylases, transketolases, and alpha-oxoacid dehydrogenases.
• TPP binding is essential for enzymes such as transketolase, pyruvate dehydrogenase, and alpha-ketoglutarate dehydrogenase, linking it to central carbon metabolism and energy production.
• The TPP riboswitch is a structured RNA element that binds TPP and regulates gene expression in bacteria, fungi, and plants, making it a model for ligand-induced RNA folding.
• Defects in thiamine transport and metabolism, including impaired TPP binding, cause severe neurological and metabolic disorders such as Wernicke encephalopathy and Leigh syndrome.
• TPP analogues are being developed as inhibitors of TPP-dependent enzymes, with potential applications in antimicrobial and anticancer therapy.
• Studying TPP binding requires integrating structural biology, biophysics, and CRISPR-based gene editing to dissect its role in health and disease.
Description
Thiamine pyrophosphate (TPP), also known as cocarboxylase, is the active form of vitamin B1 and serves as an essential coenzyme in carbohydrate metabolism. The Gene Ontology term GO:0030976, thiamine pyrophosphate binding, describes the molecular function of selectively interacting with TPP. This binding event is critical for the catalytic activity of several enzymes, including transketolase, pyruvate dehydrogenase, and alpha-ketoglutarate dehydrogenase, which are central to the pentose phosphate pathway, glycolysis, and the citric acid cycle. Researchers study TPP binding to understand fundamental metabolic regulation and to develop therapeutic strategies for diseases linked to thiamine deficiency or enzyme dysfunction. The TPP riboswitch, an RNA element that binds TPP, further highlights the broad biological significance of this interaction, as it controls gene expression in response to TPP levels in bacteria, fungi, and plants. Thus, GO:0030976 is a focal point for investigations spanning enzymology, RNA biology, and metabolic disease.
thiamine pyrophosphate binding At A Glance
| GO ID | GO:0030976 |
|---|---|
| GO term | thiamine pyrophosphate binding |
| Ontology | molecular_function |
| Synonym | aneurine pyrophosphate binding, cocarboxylase binding, diphosphothiamin binding, thiamin pyrophosphate binding, TPP binding |
| Major function | Binding to thiamine pyrophosphate, acting as a coenzyme for (de)carboxylases, transketolases, and alpha-oxoacid dehydrogenases |
| Definition source | QuickGO |
| Related cofactor | Thiamine pyrophosphate (TPP), the active form of vitamin B1 |
| Representative enzymes | Transketolase, pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase |
| Riboswitch | TPP riboswitch binds TPP to regulate gene expression |
What Is GO:0030976?
In our own words, GO:0030976 (thiamine pyrophosphate binding) is the molecular function of non-covalently and selectively binding to thiamine pyrophosphate, the diphosphoric ester of thiamine. This binding is a prerequisite for TPP to act as a coenzyme in various (de)carboxylases, transketolases, and alpha-oxoacid dehydrogenases, facilitating essential metabolic reactions.
Why Is thiamine pyrophosphate binding Important in Cell Biology?
Thiamine pyrophosphate binding is fundamental to cellular energy metabolism and biosynthetic pathways. It enables the function of key enzymes in glycolysis, the pentose phosphate pathway, and the citric acid cycle, thereby influencing ATP production and redox balance. Dysregulation of TPP-dependent enzymes is associated with severe neurological and metabolic disorders, and TPP analogues are being explored as antimicrobial and anticancer agents. Moreover, the TPP riboswitch provides a paradigm for understanding RNA-ligand interactions and gene regulation. Therefore, studying GO:0030976 is crucial for both basic biology and translational medicine.
• TPP binding is required for the activity of transketolase, which links the pentose phosphate pathway to glycolysis.
• Pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase depend on TPP binding for oxidative decarboxylation in the citric acid cycle.
• Defects in thiamine transport and metabolism lead to neurological disorders such as Wernicke encephalopathy and Leigh syndrome.
• The TPP riboswitch regulates gene expression in response to TPP levels, affecting thiamine biosynthesis and transport.
• TPP analogues that inhibit TPP-dependent enzymes are promising leads for antimicrobial and anticancer therapies.
• Understanding TPP binding aids in the design of drugs targeting metabolic pathways in cancer and infectious diseases.
• TPP binding is a model system for studying coenzyme-enzyme interactions and RNA-ligand recognition.
• CRISPR-based editing of genes encoding TPP-binding proteins can reveal their roles in cellular metabolism and disease.
Molecular Mechanism of thiamine pyrophosphate binding
Substrate recognition and binding pocket
In simple terms: TPP fits into a specific pocket in enzymes or RNA like a key in a lock.
TPP binds to a conserved pocket in TPP-dependent enzymes, where the pyrimidine ring and thiazolium moiety form hydrogen bonds and hydrophobic interactions with surrounding residues. In transketolase, the binding involves a divalent metal ion that coordinates the pyrophosphate group, as shown by equilibrium binding studies. For the TPP riboswitch, π-stacking interactions between TPP and conserved nucleotides are critical for high-affinity binding, as revealed by quantum chemical calculations and docking.
Conformational changes upon binding
In simple terms: When TPP binds, the protein or RNA changes shape to lock it in place.
Ligand binding often induces conformational changes that stabilize the TPP-bound state. The TPP riboswitch undergoes tertiary structure formation upon TPP binding, as demonstrated by thermodynamic analysis showing ligand-induced folding. In enzymes, TPP binding can trigger loop movements that close the active site, enhancing catalysis.
Catalytic role of TPP
In simple terms: TPP acts as a chemical helper that enables enzymes to break or form bonds.
The thiazolium ring of TPP generates a reactive ylide that attacks substrates, facilitating decarboxylation or transketolation. This mechanism is conserved in enzymes such as pyruvate dehydrogenase and transketolase. TPP analogues that mimic the ylide intermediate can inhibit these enzymes, as shown for triazole-based thiamine analogues and open-chain thiamine analogues.
Regulation by TPP riboswitch
In simple terms: In some organisms, TPP binding to RNA turns genes on or off.
The TPP riboswitch is an RNA element that binds TPP and regulates gene expression by terminating transcription or blocking translation. Its binding affinity and specificity are governed by conserved structural elements, and thermodynamic studies have quantified the energetics of ligand binding and folding. This riboswitch is found in bacteria, fungi, and plants, where it controls thiamine biosynthesis and transport genes.
Inhibition by TPP analogues
In simple terms: Synthetic molecules that look like TPP can block its binding and shut down enzymes.
Triazole-based thiamine analogues and open-chain thiamine analogues act as inhibitors of TPP-dependent enzymes by competing with TPP for binding. These compounds exploit the metal-binding properties of the pyrophosphate group and the structural requirements of the active site, offering potential for drug development.
Key Genes Involved in GO:0030976 thiamine pyrophosphate binding
The following genes encode proteins or RNA elements that bind thiamine pyrophosphate and are central to the function of GO:0030976.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TKT | Transketolase, a TPP-dependent enzyme in the pentose phosphate pathway | Mutations cause transketolase deficiency; target for metabolic studies |
| PDHA1 | Pyruvate dehydrogenase E1 alpha subunit, binds TPP | Defects cause pyruvate dehydrogenase deficiency and Leigh syndrome |
| PDHB | Pyruvate dehydrogenase E1 beta subunit, binds TPP | Mutations affect enzyme activity and energy metabolism |
| DLD | Dihydrolipoamide dehydrogenase, part of PDH complex | Defects lead to E3 deficiency and neurological disorders |
| OGDH | Alpha-ketoglutarate dehydrogenase, TPP-dependent | Involved in citric acid cycle; linked to neurodegeneration |
| DLST | Dihydrolipoamide succinyltransferase, part of OGDH complex | Mutations affect alpha-ketoglutarate dehydrogenase activity |
| THI5 | Thiamine biosynthesis enzyme in yeast, binds TPP | Model for thiamine metabolism and riboswitch regulation |
| thiC | Thiamine biosynthesis protein in bacteria | Target for antimicrobial development |
| thiM | TPP riboswitch-associated gene in bacteria | Model for RNA-ligand interactions |
| THI4 | Thiamine thiazole synthase in plants and fungi | Involved in thiamine biosynthesis and stress responses |
| SLC19A2 | Thiamine transporter, affects intracellular TPP levels | Mutations cause thiamine-responsive megaloblastic anemia |
| SLC19A3 | Thiamine transporter, brain-specific | Defects cause biotin-responsive basal ganglia disease |
| SLC25A19 | Mitochondrial thiamine pyrophosphate carrier | Mutations cause Amish microcephaly |
| TPK1 | Thiamine pyrophosphokinase, synthesizes TPP | Defects cause thiamine metabolism dysfunction |
| NFS1 | Iron-sulfur cluster assembly, affects TPP enzymes | Linked to mitochondrial function |
| LIAS | Lipoyl synthase, required for TPP-dependent complexes | Mutations cause lipoic acid biosynthesis defects |
| GCSH | Glycine cleavage system H protein, TPP-dependent | Defects cause non-ketotic hyperglycinemia |
| AMT | Glycine cleavage system T protein, TPP-dependent | Mutations cause glycine encephalopathy |
How Is thiamine pyrophosphate binding Regulated?
Thiamine pyrophosphate binding is regulated at multiple levels. Intracellular TPP levels are controlled by thiamine transporters (SLC19A2, SLC19A3, SLC25A19) and thiamine pyrophosphokinase (TPK1), which synthesize TPP from thiamine. In bacteria and fungi, the TPP riboswitch directly senses TPP concentrations and regulates the expression of thiamine biosynthesis and transport genes, providing feedback control. Additionally, post-translational modifications and metal ion availability can influence TPP binding to enzymes, as seen with the requirement for divalent cations in transketolase.
thiamine pyrophosphate binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PDHA1 | Pyruvate dehydrogenase deficiency, Leigh syndrome | Knockout or point-mutation in cell lines, patient-derived iPSCs |
| SLC19A3 | Biotin-responsive basal ganglia disease | Knockout in neuronal cells, knock-in of patient mutations |
| TKT | Transketolase deficiency, cancer metabolism | Overexpression or knockout in cancer cell lines |
| OGDH | Alpha-ketoglutarate dehydrogenase deficiency, neurodegeneration | Knockout in neurons, rescue with TPP |
| TPK1 | Thiamine metabolism dysfunction | Knockout in fibroblasts, complementation with wild-type |
Thiamine deficiency and neurological disorders
Impaired TPP binding due to thiamine deficiency leads to reduced activity of TPP-dependent enzymes, causing neurological disorders such as Wernicke encephalopathy and beriberi. Defects in thiamine transport proteins (SLC19A2, SLC19A3) or TPK1 result in severe metabolic and neurological phenotypes.
Inherited metabolic diseases
Mutations in genes encoding TPP-binding enzymes, such as PDHA1, OGDH, and DLD, cause inherited metabolic disorders including pyruvate dehydrogenase deficiency, alpha-ketoglutarate dehydrogenase deficiency, and Leigh syndrome. These conditions often present with lactic acidosis and neurodegeneration.
Cancer metabolism
TPP-dependent enzymes like transketolase are upregulated in many cancers to support nucleotide synthesis and NADPH production. Inhibitors of TPP binding, such as triazole-based thiamine analogues, are being investigated as anticancer agents.
Infectious diseases
TPP-dependent enzymes are essential in pathogens like Mycobacterium tuberculosis and Plasmodium falciparum. TPP analogues that inhibit these enzymes show promise as antimicrobials, and the TPP riboswitch is a potential drug target in bacteria.
From thiamine pyrophosphate binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of TPP binding affect enzyme activity? | Knockout of TPP-binding enzyme gene in cell lines |
| Does a specific point mutation alter TPP affinity? | Point mutation knock-in of catalytic residues |
| Can a tagged TPP-binding protein be tracked in live cells? | Knock-in of fluorescent tag (e.g., GFP) at endogenous locus |
| Does overexpression of TPP-binding enzyme drive cancer growth? | Overexpression in cancer cell lines |
| Can TPP analogues inhibit TPP-dependent enzymes? | Competitive binding assays with purified proteins |
| Does the TPP riboswitch regulate gene expression? | Reporter assays with riboswitch variants |
How to Study the thiamine pyrophosphate binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Isothermal titration calorimetry | Binding affinity and thermodynamics | Characterize TPP binding to enzymes |
| Cryo-EM | High-resolution structure | Determine RNA-ligand complexes |
| Molecular docking | Predicted binding poses | Study TPP riboswitch interactions |
| CRISPR knockout screens | Gene essentiality and resistance | Identify TPP metabolism genes |
| RNA-seq | Transcriptional changes | Assess riboswitch regulation |
| Enzyme activity assays | Catalytic rate | Measure TPP-dependent enzyme function |
| Fluorescence polarization | Binding affinity | High-throughput screening of inhibitors |
| Western blot | Protein expression | Validate knockout or overexpression |
Biophysical binding assays
Isothermal titration calorimetry (ITC) and surface plasmon resonance (SPR) can measure the affinity and thermodynamics of TPP binding to enzymes or RNA. Equilibrium binding studies with transketolase have provided quantitative parameters.
Structural biology
X-ray crystallography and cryo-EM reveal the atomic details of TPP binding pockets. Recent advances in scaffold-enabled cryo-EM allow high-resolution structure determination of RNA-ligand complexes like the TPP riboswitch.
Computational docking and quantum chemistry
Molecular docking and quantum chemical calculations can predict π-stacking interactions and binding energies, as demonstrated for the TPP riboswitch.
CRISPR-based genetic screens
Genome-wide CRISPR knockout or activation screens can identify genes that modulate TPP binding or sensitivity to TPP analogues, linking genotype to metabolic phenotype.
How CRISPR Can Be Used to Study GO:0030976 thiamine pyrophosphate binding
Knockout
CRISPR knockout of genes encoding TPP-binding enzymes (e.g., TKT, PDHA1) can abolish TPP binding and reveal its role in metabolic pathways. Knockout cell lines are valuable for studying metabolic rewiring and drug sensitivity.
Point Mutation
Introducing point mutations in the TPP-binding pocket (e.g., in transketolase) can fine-tune binding affinity and catalytic activity. This approach helps dissect the contribution of individual residues to TPP recognition.
Knock-in
Knock-in of tagged versions of TPP-binding proteins (e.g., GFP or HaloTag) allows live-cell imaging and proteomic analysis. Knock-in of patient mutations can model disease-associated variants.
Overexpression
Overexpression of TPP-binding enzymes or riboswitches can mimic pathological states such as cancer metabolism or bacterial resistance. It enables gain-of-function studies and screening for inhibitors.
How EDITGENE Supports thiamine pyrophosphate binding Research
Researchers studying thiamine pyrophosphate binding-related genes often need to determine whether a candidate gene is causally involved in metabolic regulation, disease, or drug response. EDITGENE provides end-to-end CRISPR solutions to generate precisely engineered cell models, enabling rigorous functional validation of TPP-binding proteins and RNA elements.
Contact EDITGENE today to design your custom CRISPR model for thiamine pyrophosphate binding research.
Frequently Asked Questions About thiamine pyrophosphate binding
What is thiamine pyrophosphate binding?
Thiamine pyrophosphate binding (GO:0030976) is the molecular function of selectively interacting with thiamine pyrophosphate (TPP), the active form of vitamin B1, which acts as a coenzyme for several enzymes.
What genes are involved in thiamine pyrophosphate binding?
Genes encoding TPP-dependent enzymes include TKT, PDHA1, PDHB, OGDH, and DLST, as well as transporters like SLC19A2 and SLC19A3.
What is the role of TPP in metabolism?
TPP is a coenzyme for enzymes in glycolysis, the pentose phosphate pathway, and the citric acid cycle, enabling decarboxylation and transketolation reactions.
How does the TPP riboswitch work?
The TPP riboswitch binds TPP and undergoes conformational changes that regulate transcription or translation of thiamine biosynthesis genes in bacteria, fungi, and plants.
What diseases are associated with defective TPP binding?
Defects in thiamine transport or TPP-dependent enzymes cause neurological disorders such as Wernicke encephalopathy, Leigh syndrome, and thiamine-responsive megaloblastic anemia.
How can I study TPP binding in the lab?
Common methods include isothermal titration calorimetry, cryo-EM, molecular docking, and CRISPR-based genetic screens.
What are TPP analogues?
TPP analogues are synthetic compounds that mimic TPP and inhibit TPP-dependent enzymes, with potential as antimicrobial and anticancer drugs.
Can CRISPR be used to study TPP binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models allow precise dissection of TPP-binding protein function in cells.
What is the difference between thiamine and TPP?
Thiamine (vitamin B1) is the precursor; TPP is the phosphorylated active coenzyme form that binds to enzymes.
Why is TPP binding important for cancer?
Cancer cells often upregulate TPP-dependent enzymes like transketolase to support growth, making TPP binding a potential therapeutic target.
Conclusion
Thiamine pyrophosphate binding (GO:0030976) is a fundamental molecular function that underpins central carbon metabolism, energy production, and gene regulation. Its role in health and disease, from neurological disorders to cancer, makes it a compelling target for research. By combining structural, biophysical, and CRISPR-based approaches, scientists can unravel the precise mechanisms of TPP recognition and develop novel therapeutics. EDITGENE's suite of CRISPR services empowers researchers to create tailored cell models for studying TPP-binding proteins and their roles in disease.
References
- 1. Li Y et al.. 2024. Macrophage P2Y6 receptor deletion attenuates atherosclerosis by limiting foam cell formation through phospholipase Cβ/store-operated calcium entry/calreticulin/scavenger receptor A pathways.. Eur Heart J 45(4):268-283 PMID: 38036416
- 2. Ho TCS et al.. 2024. Triazole-Based Thiamine Analogues as Inhibitors of Thiamine Pyrophosphate-Dependent Enzymes: 1,3-Dicarboxylate for Metal Binding.. ACS Omega 9(41):42245-42252 PMID: 39431096
- 3. Wakchaure PD et al.. 2022. Unraveling the Role of π-Stacking Interactions in Ligand Binding to the Thiamine Pyrophosphate Riboswitch with High-level Quantum Chemical Calculations and Docking Study.. J Phys Chem B 126(5):1076-1084 PMID: 35089046
- 4. Chan AHY et al.. 2023. Open-chain thiamine analogues as potent inhibitors of thiamine pyrophosphate (TPP)-dependent enzymes.. Org Biomol Chem 21(32):6531-6536 PMID: 37522836
- 5. Kochetov GA et al.. 1975. The binding of thiamine pyrophosphate with transketolase in equilibrium conditions.. Biochem Biophys Res Commun 63(4):924-30 PMID: 1093550
- 6. Haack DB et al.. 2025. Scaffold-enabled high-resolution cryo-EM structure determination of RNA.. Nat Commun 16(1):880 PMID: 39837824
- 7. Brown G. 2014. Defects of thiamine transport and metabolism.. J Inherit Metab Dis 37(4):577-85 PMID: 24789339
- 8. Kulshina N et al.. 2010. Thermodynamic analysis of ligand binding and ligand binding-induced tertiary structure formation by the thiamine pyrophosphate riboswitch.. RNA 16(1):186-96 PMID: 19948769
